Join Hep B United and NASTADfor a webinar on Hepatitis B and the Opioid Crisis. Up to 2.2 million Americans and more than 292 million people worldwide are chronically infected with hepatitis B (HBV). Hepatitis B is the world’s most common serious liver infection and the deadliest vaccine-preventable disease in the world. Without diagnosis or intervention, 1 in 4 chronically infected with HBV will go on to develop liver failure and/or liver cancer.
Despite the availability of highly effective vaccines, barriers to preventing hepatitis B infection in the U.S. remain. For the first time since 2006, the number of reported acute HBV cases across the country is rising. Parts of the country hardest hit by the opioid epidemic are facing a rise in acute HBV infection associated with injection drug use. This session will discuss the rise in acute HBV infection in the U.S., from Tennessee, West Virginia, and Maine, and how communities and health departments are responding to the epidemics.